Skip to main content
Clinical Trials/NCT02108236
NCT02108236
Unknown
Not Applicable

Effectiveness and Safety of Acupuncture for Obesity and Over-weight People

Heilongjiang University of Chinese Medicine1 site in 1 country110 target enrollmentMay 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
Heilongjiang University of Chinese Medicine
Enrollment
110
Locations
1
Primary Endpoint
body mass index(BMI)
Last Updated
11 years ago

Overview

Brief Summary

To determine the efficacy and safety of acupuncture for obesity and overweight people in China.

Registry
clinicaltrials.gov
Start Date
May 2014
End Date
October 2015
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Heilongjiang University of Chinese Medicine
Responsible Party
Principal Investigator
Principal Investigator

Wang Ling Shu

the head of institute of chinese medicine and translational science of First Affiliated Hospital

Heilongjiang University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • The individuals is phlegm-dampness constitution and female.
  • Age is between 18 and 45 years.
  • BMI is between 24 and
  • The individuals voluntarily sign the informed consent form.
  • The individuals live in Harbin City of China.

Exclusion Criteria

  • Secondary obesity, eg:pituitary diseases, hypothalamic disorder, hypothyroidism, pancreatic diseases,hyperadrenocorticism, postmenopausal obesity etc.
  • The individuals with server cardiovascular and cerebrovascular diseases and cancer.
  • Having therapy for obesity in the last three months.
  • The individuals do not adhere to the treatment or are with other treatments.
  • Female individuals with pregnancy, lactation and planning a pregnancy in the two months.
  • Critical patients or patients combined with liver and kidney damage.
  • Individuals with visual and auditory memory disorders or psychosis.

Outcomes

Primary Outcomes

body mass index(BMI)

Time Frame: 2 month after treatment

Secondary Outcomes

  • Blood sugar(2 month after treatment)
  • Triglycerides(2 month after treatment)
  • waist-to-hip ratio (WHR)(2 month after treatment)
  • Total cholesterol(2 month after treatment)
  • High-density lipoprotein cholesterol(2 month after treatment)
  • Low-density lipoprotein cholesterol(2 month after treatment)

Study Sites (1)

Loading locations...

Similar Trials